[go: up one dir, main page]

SE7904353L - Farmaceutisk doseringskomponent - Google Patents

Farmaceutisk doseringskomponent

Info

Publication number
SE7904353L
SE7904353L SE7904353A SE7904353A SE7904353L SE 7904353 L SE7904353 L SE 7904353L SE 7904353 A SE7904353 A SE 7904353A SE 7904353 A SE7904353 A SE 7904353A SE 7904353 L SE7904353 L SE 7904353L
Authority
SE
Sweden
Prior art keywords
pharmaceutical dosage
dosage component
microencapsulated
beta
prepared
Prior art date
Application number
SE7904353A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
P M John
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE7904353L publication Critical patent/SE7904353L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7904353A 1978-05-18 1979-05-17 Farmaceutisk doseringskomponent SE7904353L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/907,036 US4153677A (en) 1978-05-18 1978-05-18 Controlled-release composition

Publications (1)

Publication Number Publication Date
SE7904353L true SE7904353L (sv) 1979-11-19

Family

ID=25423420

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904353A SE7904353L (sv) 1978-05-18 1979-05-17 Farmaceutisk doseringskomponent

Country Status (15)

Country Link
US (1) US4153677A (xx)
JP (1) JPS54160712A (xx)
AU (1) AU525125B2 (xx)
BE (1) BE876306A (xx)
CA (1) CA1123737A (xx)
CH (1) CH640133A5 (xx)
DE (1) DE2920254A1 (xx)
DK (1) DK203879A (xx)
FR (1) FR2425853A1 (xx)
GB (1) GB2020973B (xx)
IT (1) IT1114247B (xx)
LU (1) LU81293A1 (xx)
NL (1) NL7903725A (xx)
NZ (1) NZ190394A (xx)
SE (1) SE7904353L (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4847302A (en) * 1984-06-04 1989-07-11 Merck & Co., Inc. Use of certain compounds in livestock food as growth promotants for better feed utilization and improved carcass composition
IT1176853B (it) * 1984-10-02 1987-08-18 Eurand Spa Procedimento per ottenere una formulazione a rilascio controllato di componenti solubili in acqua
CA1266235A (en) * 1985-03-25 1990-02-27 Wallace E. Becker Tablet composition for drug combinations
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4761421A (en) * 1985-05-08 1988-08-02 Merck & Co., Inc. Use of certain compounds in livestock food as growth promotants for better feed utilization and improved carcass composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US5084287A (en) * 1990-03-15 1992-01-28 Warner-Lambert Company Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat
US6812233B1 (en) * 1991-03-06 2004-11-02 Emory University Therapeutic nucleosides
CA2067975C (en) * 1991-05-20 2003-01-14 Cynthia M. Blase Buffered matrix aspirin tablet
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
PT1711169E (pt) * 2004-02-04 2007-07-23 Alembic Ltd Minicomprimidos revestidos de libertação prolongada de cloridrato de venlafaxina.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
US3488418A (en) * 1965-11-18 1970-01-06 Sterling Drug Inc Sustained relief analgesic composition
FR5788M (xx) * 1965-11-18 1968-03-18
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
US3904671A (en) * 1969-04-01 1975-09-09 Sterling Drug Inc Esters of 3-(hydroxy or hydroxymethyl)-4-hydroxyphenyl aminomethyl ketones
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3632739A (en) * 1969-12-29 1972-01-04 Sandoz Ag Solid sustained release pharmaceutical preparation
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US3909444A (en) * 1971-08-05 1975-09-30 Ncr Co Microcapsule
GB1468172A (en) * 1973-03-28 1977-03-23 Benzon As Alfred Oral drug preparations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition

Also Published As

Publication number Publication date
DK203879A (da) 1979-11-19
US4153677A (en) 1979-05-08
IT7922743A0 (it) 1979-05-17
AU4695879A (en) 1979-11-22
GB2020973A (en) 1979-11-28
AU525125B2 (en) 1982-10-21
CH640133A5 (fr) 1983-12-30
JPS54160712A (en) 1979-12-19
NL7903725A (nl) 1979-11-20
IT1114247B (it) 1986-01-27
FR2425853A1 (fr) 1979-12-14
BE876306A (fr) 1979-11-19
DE2920254A1 (de) 1979-11-22
GB2020973B (en) 1982-12-15
CA1123737A (en) 1982-05-18
LU81293A1 (fr) 1979-12-07
NZ190394A (en) 1980-11-28

Similar Documents

Publication Publication Date Title
SE7904353L (sv) Farmaceutisk doseringskomponent
SE8103843L (sv) Farmaceutisk mixtur
NO161740C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 9-(1,3-dihydroksy-2-propoksymetyl) guanin.
SE8001747L (sv) Forfarande for framstellning av 1-fluorerade vitamin d-foreningar
BR8604535A (pt) Composicao inseticida compreendendo mais que um ingrediente ativo
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
ES8401508A1 (es) Procedimiento para preparar una emulsion acuosa estable de revestimiento del tipo aceite-en-agua.
IT8321364A1 (it) DERIVATI DI β, γ -DIIDROPOLIPRENIL ALCOOL E COMPOSIZIONE FARMACEUTICA CONTENENTE UN COMPOSTO DI POLIPRENILE
IT1105605B (it) Composti a base di alcossisilani procedimento per la loro preparazione e loro impiego come fluidi funzionali
ES553069A0 (es) Procedimiento para la preparacion de un polvo para heridas, libremente fluyente, homogeneo, conteniendo yodoforo
MX5702E (es) Procedimiento para la preparacion de una mezcla de esteroisomeros de alfa-ciano-3-fenoxibencil-2-(4-clorofenil)isovalerato
IT1160924B (it) Procedimento per la preparazione dell'alcool beta-fenil-etilico
DK158489C (da) Fremgangsmaade til fremstilling af et acesulfamholdigt praeparat
IT8023262A0 (it) Composizioni farmaceutiche contenenti estratti di edera rampicante.
IT1057054B (it) Procedimento per la preparazione di composti stagno tetraorganici
IT7921652A0 (it) Preparato farmaceutico contenente un derivato di acido orto-amminobenzoico come imgrediente attivo.
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
AR245688A1 (es) Compuestos trigliceridos de amonio cuaternario, su preparacion y su uso.
ES499825A0 (es) Procedimiento para la preparacion de composiciones insecticidas liquidas a base de amidino-hidrazonas.
ES522904A0 (es) Un metodo para obtener una preparacion farmaceutica que contiene un derivado de 16 beta-etil-17 beta-hidroxi-estrano.
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
NL7707501A (nl) Uitwendig toe te dienen geneesmiddelpreparaat.
IT1156989B (it) Procedimento per la preparazione della i.4 bis piperonil piperazina e dei composti analoghi
DK27177A (da) Fremgangsmade til fremstilling af et legemiddel i pelletform
FR2432868A1 (fr) Medicaments mucolytiques a base de benzamidoalkyl-mercaptans

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7904353-5